Clostridioides difficile-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms

Clostridioides difficile-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms

A clinically relevant risk factor forClostridioides difficile-associated dis-ease (CDAD) is recent antibiotic treatment. Although broad-spectrum antibioticshave been shown to disrupt the structure of the gut microbiota, some antibioticsappear to increase CDAD risk without being highly active against...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Kester, Jemila C., Brubaker, Douglas K., Velazquez, Jason, Wright, Charles, Lauffenburger, Douglas A., Griffith, Linda G.
מחברים אחרים: Massachusetts Institute of Technology. Department of Biological Engineering
פורמט: Article
שפה:English
יצא לאור: American Society for Microbiology 2020
נושאים:
Pharmacology (medical)
Pharmacology
Infectious Diseases
גישה מקוונת:https://hdl.handle.net/1721.1/124762

אינטרנט

https://hdl.handle.net/1721.1/124762

פריטים דומים